DECK: Overview of ER+, HER2-, ABC including ER-Targeted Therapies
This slide deck provides an overview of the ER+, HER2- advanced breast cancer landscape, including information on ER targeted therapies, mechanisms of resistance to ET +/- CDK4/6 inhibitors, & scientific advancements in the form of next-generation ETs.
Date of Last Review: April 29, 2024
Are you satisfied with this content?